FDA Class I Recall: Stealth S8 Clinical Software Application, REF: 9735762, CE0344,… by Medtronic Navigation, Inc. — Recall Details

Key facts

What consumers should do

Facilities, clinicians, and consumers holding an affected unit or lot of Stealth S8 Clinical Software Application, REF: 9735762, CE0344, Rx Only. Used in the StealthStation System as an aid for locating anatomical structures in either open or percutaneous neurosurgical procedures. should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Medtronic Navigation, Inc.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Medtronic Navigation, Inc. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Medtronic Navigation, Inc. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.

What this classification means

A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class I, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.

Medtronic Navigation, Inc.’s FDA history

Argus HQ has recorded 10 total FDA actions tied to Medtronic Navigation, Inc.: 0 warning letters, 10 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

Where can I verify this recall directly with FDA?

The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.

Is Stealth S8 Clinical Software Application, REF: 9735762, CE03 recalled?

Yes. FDA lists a Class I recall by Medtronic Navigation, Inc. for Stealth S8 Clinical Software Application, REF: 9735762, CE0344, Rx Only. Used in the StealthStation System as an aid for locating anatomical structures in either open or percutaneous neurosurgical procedures., reported 20240515, with status "Ongoing." FDA recall number: Z-1776-2024.

What is the recall class for Medtronic Navigation, Inc.'s recall?

FDA classified this recall as Class I. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death.

Why was Stealth S8 Clinical Software Application, REF: 9735762, CE03 recalled?

FDA's recall record states the reason as: Due to a software issue, there is the potential for a missing digit, letter, or decimal in either the "distance to target" or "tip stop point" display during navigation.

Related enforcement actions

• Recall: Medtronic Navigation, Inc. — Class II recall: Medtronic PIN, 100mm STERILE PERCUTANEOUS REF: 9733235 Medtronic PIN, 150MM,… →
• Recall: Medtronic Navigation, Inc. — Class II recall: StealthStation S8 App versions 1.3.0 and 1.3.2, (Model # 9735762) The Stealth… →
• Recall: Medtronic Navigation, Inc. — Class II recall: Medtronic, REF 9733235, Pin, 100mm, STERILE, PERCUTANEOUS →
• Recall: Medtronic Navigation, Inc. — Class II recall: Medtronic, REF 9733236, Pin, 150mm, STERILE, PERCUTANEOUS →
• Recall: Medtronic Navigation, Inc. — Class I recall: StealthStation S8 Application version 2.0 and 2.0.1 (Part 9735762) The Stealt… →
• Recall: Medtronic Navigation, Inc. — Class I recall: StealthStation Cranial Software, Model: 9735585, used with StealthStation S7/i7… →
• Recall: Medtronic Navigation, Inc. — Class I recall: StealthStation Cranial Software, Models: 9735585, 9735586 (kit), 9735587 (kit),… →
• Recall: Medtronic Navigation, Inc. — Class II recall: AxiEM" Non-Invasive Patient Tracker →